Distinct Early Serological Signatures Track with SARS-CoV-2 SurvivalCaroline Atyeo, Galit Alter, Denise J. McCulloch et al.|Immunity|2020Cited by 420
SARS-CoV-2-specific ELISA developmentVicky Roy, Galit Alter, Stephanie Fischinger et al.|Journal of Immunological Methods|2020Cited by 97
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine designCarolin Loos, Wivine Burny|npj Vaccines|2023Cited by 33